OpicApone Sleep dISorder

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

March 29, 2023

Study Completion Date

March 29, 2023

Conditions
Parkinson Disease
Interventions
DRUG

Opicapone

Oral administration, once daily, at least 1 hour before or after the last daily dose of L-dopa/DDCI

Trial Locations (1)

4835-044

Hospital da Senhora da Oliveira - Guimarães, E.P.E, Serviço de Neurologia, Guimarães

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY